25
Participants
Start Date
September 30, 1998
Primary Completion Date
July 31, 2001
Study Completion Date
July 31, 2001
fosbretabulin disodium
Ireland Cancer Center, Cleveland
National Cancer Institute (NCI)
NIH
Case Comprehensive Cancer Center
OTHER